DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 59 · January 2021 DOI: 10.1055/s-011-50135

Deutsche Arbeitsgemeinschaft zum Studium der Leber
37. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Münster, 29.-30.01.2021

Kongresspräsident: Prof. Dr. Andreas Pascher

2.4
Trebicka, J; Gu, W; Lédinghen, VD; Aubé, C; Krag, A; Thiele, M; Jansen, C: 2D Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease: AIXPLORER PREDICT and VALIDATE
2.5
2.6
Bowlus, C; Trauner, M; Liberman, A; Malecha, E.; MacConell, L; Kremer, A; Nevens, F: Long-Term Efficacy and Safety of Obeticholic Acid in Patients With PBC From POISE Grouped by Risk of Disease Progression
2.7
Buescher, G; Villard, C; Bergquist, A; Zhou, T; Weismüller, T; Wiestler, M; Ehlken, H; Rösch, T; Huber, S; Lohse, AW; Sebode, M: Percutaneous transhepatic cholangiodrainage in patients with PSC: a multicentre, retrospective analysis
2.8
Wang, S; Feng, R; Wang, S; Liu, H; Shao, C; Munker, S; Liebe, H; Meyer, C; Schiergens, T; Toni, ED; Ebert, MPA; Dooley, S; Ding, H; Weng, H: LPS dosage-dependently regulates FOXA2 expression through NFkB signaling and thus determining BSEP expression in ACLF
2.9
Kneifel, F; Flammang, I; Becker, F; Vogel, T; Radünz, S; Houben, P; Schmidt, H; Pascher, A; Brockmann, JG: First year experience of liver graft normothermic machine perfusion at University hospital Münster
2.10
Flammang, I; Kneifel, F; Becker, F; Houben, P; Radünz, S; Vogel, T; Pascher, A; Brockmann, JG: Assessment of liver allograft viability during ex vivo normothermic machine perfusion using the MS2 score
2.11
2.12
Stindt, J; Dröge, C; Wammers, M; Philippski, P; Wiek, C; Hanenberg, H; Häussinger, D; Luedde, T; Keitel, V: Testing for Antibody-Induced BSEP Deficiency (AIBD) using a Novel Cell-based Assay
2.13
Queck, A; Schwierz, L; Jansen, C; Uschner, FE; Praktiknjo, M; Chang, J; Brol, MJ; Strassburg, CP; Lehmann, J; Meyer, C; Trebicka, J: Der Stellenwert des portal-hepatischen Druckgradienten in der Therapie des refraktären Aszites durch TIPS
2.14
Reichert, MC; Greiner, R; Zipprich, A; Ripoll, C; Krawczyk, M; Lammert, F: HSD17B13 and MBOAT7 as modulators of PNPLA3-associated cirrhosis
2.15
Alkhouri, N; Sanyal, A; Ratziu, V; Rinella, M; Loomba, R; Dufour, JF; Mozaffari, E; Granston, T; Zhou, H; Shringarpure, R; MacConell, L; Bedossa, P; Goodman, Z; Younossi, Z; Anstee, Q; von Roenn, N; Harrison, S; Geier, A: Obeticholic Acid Efficacy in Patients With NASH Monitored Using Noninvasive Tests: Post Hoc Analysis of REGENERATE Trial
2.16
Jördens, M; Pereira, J; Görg, B; Herebian, D; Lüdde, T; Häussinger, D: 8-oxo-7,8-dihydro-guanosine-urine levels are elevated in patients with liver cirrhosis and hepatic encephalopathy
2.17
Fromme, M; Schneider, CV; Hamesch, K; Ellis, P; Pereira, V; Pons, M; Genesca, J; Miravitlles, M; Nuñez, A; Reichert, M; Benini, F; Burbaum, B; Woditsch, V; Schaefer, B; Zoller, H; Hurst, JR; Lomas, DA; Verbeek, J; Nevens, F; Janciauskiene, S; Chorostowska-Wynimko, J; Lammert, F; Clark, V; Griffiths, WJ; Turner, A; McElvaney, NG; Trautwein, C; Strnad, P: Leberphänotyp bei Erwachsenen mit compound-heterozygotem Alpha1-Antitrypsin-Mangel (Genotyp Pi*SZ)
2.18
Kremer, WM; Labenz, C; Weinmann, A; Galle, PR; Sprinzl, MF: Ultraschallgesteuerte Messung der Sarkopenie
2.19
Reuther, J; Gülow, K; Reuther, S; Spreiter, L; Schmid, S; Müller-Schilling, M: Machine-learning-based analysis of liver injuries in COVID-19 patients
2.20
Nagel, M; Arslanow, A; Nguyen-Tat, M; Wörns, MA; Reichert, M; Heil, FJ; Mainz, D; Zimper, G; Zwerenz, B; Jäger, J; Binder, H; Bogatyreva, L; Farin-Glattacker, E; Fichtner, U; Graf, E; Stelzer, D; van Ewijk, R; Ordner, J; Velthuis, L; Lammert, F; Galle, PR: SEAL program - Early detection of liver fibrosis and cirrhosis by screening of the general population
2.21
Nickel, S; Tautenhahn, HM; Vlaic, S; Christ, M; Henschler, R; Tautenhahn, F; Burger, C; Kühne, H; Erler, S; Roth, A; Wild, C; Brach, J; Hamad, S; Gittel, C; Baunack, M; Lange, U; Broschewitz, J; Stock, P; Metelmann, I; Bartels, M; Pietsch, UC; Krämer, S; Eichfeld, U; Dooley, S; Christ, B: Mesenchymal stromal cells provide hepatic support after extended hepatectomy by modulating thrombospondin-1/TGF-β
2.22
Katou, S; Masthoff, M; Wildgruber, M; Köhler, M; Heindel, W; Wilms, C; Schmidt, H; Strücker, B; Pascher, A; Morgül, H: Preliminary results on simultaneous portal and hepatic vein embolization prior to major hepatectomy
2.23
Brunner, SM; Brennfleck, FW; Junger, H; Knoppke, B; Melter, M; Schlitt, HJ: Auxiliary two-staged partial resection (ASPIRE) LTx for end-stage liver disease to avoid small-for-size situations
2.24
Juratli, M; Sliwinski, S; Oppermann, E; Lorentzen, A; Pascher, A; Bechstein, WO; Heikenwälder, M: Ezrin-polarized circulating tumor cells as a potential biomaker in hepatocellular carcinoma
2.26
Neubert, P; Haderer, M; Gschwendtner, H; Gülow, K; Kunst, C; Müller-Schilling, M: Investigating spontaneous bacterial peritonitis – a novel role of the p53 family in bacteria-host-interaction
2.27
Ferstl, P; Picard, K; Schmuck, L; Krajnc, JR; Feller, L; Schultze, TG; Schulz, M; Uschner, FE; Erasmus, HP; Gu, W; Mücke, MM; Wichelhaus, TA; Hogardt, M; Waidmann, O; Welker, MW; Zeuzem, S; Kempf, VAJ; Trebicka, J: Epidemiologie von gesicherten bakteriellen Infektionen bei Patienten mit Leberzirrhose in den Jahren von 2010 bis 2019
2.29
Kaddu-Mulindwa, D; von Martial, M; Thiel-Bodenstaff, A; Lesan, V; Ewen, S; Mahfoud, F; Lammert, F; Krawczyk, M: LIVER STIFFNESS MEASUREMENTS IN EMERGENCY TRIAGE PREDICT INPATIENT HEALTH CARE UTILIZATION
2.30
Burbaum, B; Fromme, M; Schneider, C; Pereira, V; Hamesch, K; Pons, M; Reichert, MC; Benini, F; Ellis, P; Thorhauge, K; Mandorfer, M; Woditsch, V; Chorostowska-Wynimko, J; Nuñez, A; Schäfer, B; Zoller, H; Janciauskiene, S; Abreu, N; Jasmins, L; Gaspar, R; Gomes, C; Schneider, KM; Trauner, M; Krag, A; Gooptu, B; Thorburn, D; Marshall, A; Hurst, JR; Lomas, DA; Lammert, F; Gaisa, NT; Clark, V; Griffiths, WJ; Trautwein, C; Turner, AM; McElvaney, NG: Populations-basierte Erfassung des Leberphänotyps bei Alpha1-Antitrypsinmangel
2.31
Sturm, L; Roth, L; Bettinger, D; Zoldan, K; Boettler, T; Huber, JP; Kaeser, R; Kreisel, W; Thimme, R; Schultheiss, M: Blood cyclic guanosine monophosphate levels as potential marker of portal hypertension in patients with liver cirrhosis
2.32
Pavel, V; Mester, P; Gülow, K; Kunst, C; Aschenbrenner, L; Müller-Schilling, M; Schmid, S: Biomarkers for Diagnosis of Sepsis in Patients with Liver Cirrhosis
2.33
Loosen, SH; Roderburg, C; Ulmer, TF; Knoefel, W; Schnitzbauer, AA; Trebicka, J; Tacke, F; Bock, H; Keitel, V; Trautwein, C; Bode, JG; Neumann, UP; Luedde, T: Hospital mortality and current developments of liver transplantation in Germany: A systematic 10-year analysis
2.34
Klindt, C; Jensen, BE; Feldt, T; Schimmöller, L; Antoch, G; Senff, T; Hauka, S; Timm, J; Seidl, M; Esposito, I; Luedde, T; Bode, JG; Keitel, V: Biliary injury in patients with severe COVID-19 is most likely not caused by direct viral damage
2.35
Schulz, M; Mengers, J; Ferstl, PG; Uschner, FE; Queck, A; Brol, MJ; Ackermann, N; Guttenberg, G; Graf, C; Mücke, MM; Peiffer, KH; Welker, MW; Grünewaldt, A; Bojunga, J; Zeuzem, S; Rohde, G; Trebicka, J: Modifikation des CLIF-C ACLF-Scores für die Prognoseabschätzung bei Schutzintubation und Lungenversagen.
2.36
Becker, F; Kneifel, F; Schmidt, H; Pascher, A; Brockmann, JG: Is there a too old in liver donors? An age stratified analysis of elderly liver donors above 65
2.37
Sollors, J; Schlevogt, B; Schmidt, H; Wörns, MA; Galle, PR; Bergner, R; Hetjens, S; Weis, CA; Ebert, M; Teufel, A: Hepatic sarcoidosis
2.38
Erasmus, HP; Bektas, R; Orland, K; Trifonova, S; Gu, WY; Uschner, FE; Brol, MJ; Chang, J; Praktiknjo, M; Strassburg, CP; Trebicka, J; Jansen, C: Variceal Bleeding has Increased Mortality Compared to Non-Variceal Bleeding only in Males.
2.39
Mücke, MM; Rüschenbaum, S; Mayer, A; Mücke, VT; Schwarzkopf, KM; Zeuzem, S; Kehrmann, J; Scholtysik, R; Lange, CM: Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis
2.40
Gottlieb, A; Lange, J; Sowa, JP; Heider, D; Canbay, A: Liver cirrhosis, age, and bilirubin could be prognostic for mortality in pancreatitis
2.41
Silveira, C; Katou, S; Schmid, F; Schäfer, L; Naim, T; Morgül, H; Pascher, A; Struecker, B: Outcome after liver resection for hepatic hemangiosarcoma
2.42
Mohr, A; Kneifel, F; Becker, F; Pascher, A; Hölzen, JP: Beneficial Effects of Nuclear Magnetic Resonance Therapy on Liver Regeneration
2.43
Gairing, SJ; Kloeckner, R; Pitton, MB; Baumgart, J; von Auer, C; Lang, H; Galle, PR; Foerster, F; Schattenberg, J: The multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension
2.44
Schmid, F; Katou, S; Silveira, C; Schäfer, L; Naim, T; Strücker, B; Pascher, A; Morgül, MH: Liver Resection for Non-colorectal, Non-neuroendocrine Metastases
2.45
Sollors, J; Kallinowski, B; Gaiser, T; Antoni, C; Ebert, M; Teufel, A: De novo Crohn disease after liver transplantation: Case Report and Review of the literature